Bisphosphonates on mortality and cardiovascular risk
نویسندگان
چکیده
منابع مشابه
Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
BACKGROUND AND OBJECTIVES Some evidence suggests that bisphosphonates may reduce atherosclerosis, while concerns have been raised about atrial fibrillation. We conducted a meta-analysis to determine the effects of bisphosphonates on total adverse cardiovascular (CV) events, atrial fibrillation, myocardial infarction (MI), stroke, and CV death in adults with or at risk for low bone mass. METHO...
متن کاملAlcohol Consumption, Cardiovascular Risk Factors, and Mortality
Multivariate analysis of the association at baseline between problem drinking and cardiovascular risk factors among 1,233 white male employees of the Chicago Peoples Gas Company age 40-59 showed the 38 problem drinkers with significantly higher blood pressures and cigarette consumption and significantly lower relative weights than the others. Similar analyses among 1,899 white male employees of...
متن کاملRitual Risk: Incense Use and Cardiovascular Mortality
Numerous studies have examined exposures to indoor combustion products such as secondhand smoke and emissions from burning of solid fuels. However, only a few have examined incense burning as a potential health threat, even though incense is commonly used for religious and ritual purposes in China, Taiwan, Singapore, India, and Middle Eastern nations. In this issue of EHP, investigators report ...
متن کاملHomoarginine, kidney function and cardiovascular mortality risk.
BACKGROUND Homoarginine is a novel biomarker for cardiovascular diseases. In the present large cohort study, we evaluate how homoarginine is linked to kidney function and examine the potential interaction of homoarginine and kidney function as predictors of cardiovascular outcomes. METHODS Serum homoarginine (mean: 2.41 ± 1.05 µmol/L), cystatin C and creatinine-based estimated GFR (eGFR, mean...
متن کاملBisphosphonates and mortality in women with CKD and the presence or absence of cardiovascular disease.
BACKGROUND AND OBJECTIVES A modest protective association between bisphosphonate prescription and mortality among women with CKD but without clinically manifest cardiovascular disease has been shown. Whether a prior cardiovascular event (myocardial infarction, stroke, or heart failure) modifies this association is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS A cohort of adult women ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Formosan Medical Association
سال: 2021
ISSN: 0929-6646
DOI: 10.1016/j.jfma.2021.04.027